We are live on ! Find out more
NSPRZ

InspireMD, Inc. Series B Warrants
NSPRZ

Delisted

NSPRZ was delisted on the 14th of March, 2022.

Back to rankings

5 hedge funds and large institutions have $99K invested in InspireMD, Inc. Series B Warrants in 2018 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 5 → 5 (0)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

66% less capital invested

Capital invested by funds: $291K → $99K (-$192K)

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$4

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$312
Name Holding Trade Value Shares
Change 		Change in
Stake
AFM
1
Anson Funds Management
Texas
$62K – – –
SM
2
Sabby Management
Florida
$36K -$312 -16,100 -0.8%
CH
3
CVI Holdings
Delaware
$1K – – –
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
– +$4 +200 +1%

NSPRZ Hedge Fund Activity: Q2 2018 in Review

5 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in InspireMD, Inc. Series B Warrants (NSPRZ) for Q2 2018, worth a combined $99K — down 66% from $291K a quarter earlier.

Fund positioning in NSPRZ was balanced in Q2 2018: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $4. The largest seller was Sabby Management, cutting an estimated $312.

  • 5 institutional investors held InspireMD, Inc. Series B Warrants (NSPRZ) as of Q2 2018, unchanged from Q1 2018.
  • Funds reported $99K of InspireMD, Inc. Series B Warrants stock for Q2 2018, down 66% quarter-over-quarter.
  • 0 funds opened new InspireMD, Inc. Series B Warrants positions in Q2 2018 and 0 closed out.
  • The largest InspireMD, Inc. Series B Warrants buyer in Q2 2018 was Susquehanna International Group, an estimated $4 added.
  • The largest InspireMD, Inc. Series B Warrants seller in Q2 2018 was Sabby Management, an estimated $312 sold.

Based on aggregated 13F filings for Q2 2018.